chitosan has been researched along with tocophersolan in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 9 (60.00) | 24.3611 |
| 2020's | 6 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balakrishnan, P; Cho, HJ; Chung, SJ; Kim, DD; Shim, CK | 1 |
| Cao, W; He, ZG; Lian, H; Liu, YH; Sun, J; Sun, YH; Wang, SL; Wang, YJ; Yu, YP | 1 |
| Dou, J; Liu, X; Zhai, G; Zhang, H; Zhang, M | 1 |
| Chu, M; Guo, Y; Liu, H; Otieno, BO; Tan, S; Xu, C; Yang, X; Zhang, Z; Zhao, S | 1 |
| Han, HK; Shao, Y; Yang, L | 1 |
| Chen, Y; Feng, S; Gao, F; Liu, W; Yin, P; Yuan, Z | 1 |
| Chen, H; Gui, YL; Huo, SJ; Kong, YY; Mu, X; Sun, JH; Xu, Q; Yu, SQ; Zhang, D; Zhou, M | 1 |
| Agrawal, P; Bharti, S; Koch, B; Kumar Mehata, A; Kumari, L; Muthu, MS; Singh, P; Singh, S; Viswanadh, MK | 1 |
| Fan, G; Gao, F; Han, L; He, X; Huang, X; Qiu, Y; Tang, X; Xu, K; Yin, P; Yuan, Y; Yuan, Z; Zhang, Y | 1 |
| Duan, W; Ha-Lien Tran, P; Tran, TTD; Wang, T; Yang, C | 1 |
| Bai, R; Bi, F; Liu, J; Qin, Y; Yong, H | 1 |
| Abdelmonsif, DA; Aly, RG; Elgindy, NA; Mohyeldin, SM; Ragab, D; Samy, WM | 1 |
| Chen, G; Li, H; Liu, M; Lu, W; Svirskis, D; Wen, J; Ying, M | 1 |
| Abd-Elsalam, WH; Ibrahim, RR | 1 |
| Bhattacharya, S; Hatware, K; Jain, A; Manthalkar, L; Phatak, N; Shah, D; Sreelaya, P | 1 |
15 other study(ies) available for chitosan and tocophersolan
| Article | Year |
|---|---|
Evaluation of protein stability and in vitro permeation of lyophilized polysaccharides-based microparticles for intranasal protein delivery.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Absorption; Administration, Intranasal; beta-Cyclodextrins; Chitosan; Freeze Drying; Humans; Hypromellose Derivatives; Methylcellulose; Muramidase; Nasal Mucosa; Particle Size; Polyethylene Glycols; Powders; Primary Cell Culture; Protein Stability; Succinates; Vitamin E | 2011 |
Supramolecular micellar nanoaggregates based on a novel chitosan/vitamin E succinate copolymer for paclitaxel selective delivery.
Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Line, Tumor; Chitosan; Delayed-Action Preparations; Diffusion; Female; Humans; Micelles; Nanocapsules; Paclitaxel; Polyethylene Glycols; Vitamin E | 2011 |
Preparation and evaluation in vitro and in vivo of docetaxel loaded mixed micelles for oral administration.
Topics: Administration, Oral; Animals; Chitosan; Docetaxel; Gastrointestinal Tract; Magnetic Resonance Spectroscopy; Male; Micelles; Microscopy, Electron, Transmission; Molecular Weight; Oligosaccharides; Rats; Rats, Wistar; Stearic Acids; Taxoids; Time Factors; Vitamin E | 2014 |
Chitosan-g-TPGS nanoparticles for anticancer drug delivery and overcoming multidrug resistance.
Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Blotting, Western; Breast Neoplasms; Carcinoma, Hepatocellular; Cell Proliferation; Chitosan; Doxorubicin; Drug Delivery Systems; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Flow Cytometry; Humans; Liver Neoplasms; Mice; Nanoparticles; Polyethylene Glycols; Polymers; Tissue Distribution; Tumor Cells, Cultured; Vitamin E; Xenograft Model Antitumor Assays | 2014 |
TPGS-chitosome as an effective oral delivery system for improving the bioavailability of Coenzyme Q10.
Topics: Administration, Oral; Animals; Antioxidants; Biological Availability; Caco-2 Cells; Cell Line, Tumor; Chemistry, Pharmaceutical; Chitosan; Drug Delivery Systems; Humans; Liposomes; Male; Particle Size; Polyethylene Glycols; Powders; Rats; Rats, Sprague-Dawley; Ubiquinone; Vitamin E | 2015 |
Vitamin E Succinate-Grafted-Chitosan Oligosaccharide/RGD-Conjugated TPGS Mixed Micelles Loaded with Paclitaxel for U87MG Tumor Therapy.
Topics: alpha-Tocopherol; Animals; Antineoplastic Agents; Cell Line, Tumor; Chitosan; Drug Carriers; Glioma; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Micelles; Nanoparticles; Oligopeptides; Oligosaccharides; Paclitaxel; Particle Size; Succinates; Vitamin E | 2017 |
Co-delivery nanoparticles with characteristics of intracellular precision release drugs for overcoming multidrug resistance.
Topics: Alginates; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Chitosan; Doxorubicin; Drug Carriers; Drug Delivery Systems; Drug Liberation; Drug Resistance, Multiple; Emulsions; Glucuronic Acid; Hexuronic Acids; Humans; Lactic Acid; Mice, Nude; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Vincristine; Vitamin E; Xenograft Model Antitumor Assays | 2017 |
Trastuzumab decorated TPGS-g-chitosan nanoparticles for targeted breast cancer therapy.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Biological Availability; Breast Neoplasms; Cell Line, Tumor; Chitosan; Docetaxel; Drug Carriers; Female; Glycoconjugates; Humans; Kidney; Liver; Lung; Molecular Targeted Therapy; Nanoparticles; Rats; Receptor, ErbB-2; Trastuzumab; Tumor Burden; Vitamin E; Xenograft Model Antitumor Assays | 2019 |
Bufalin-loaded vitamin E succinate-grafted-chitosan oligosaccharide/RGD conjugated TPGS mixed micelles demonstrated improved antitumor activity against drug-resistant colon cancer.
Topics: Animals; Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bufanolides; Chitosan; Colonic Neoplasms; Doxorubicin; Drug Resistance, Neoplasm; HCT116 Cells; Humans; Mice, Nude; Micelles; Oligopeptides; Oligosaccharides; Rhodamine 123; Tumor Burden; Vitamin E | 2018 |
Development of conjugate-by-conjugate structured nanoparticles for oral delivery of docetaxel.
Topics: Administration, Oral; Antineoplastic Agents; Breast Neoplasms; Caco-2 Cells; Cell Line, Tumor; Chitosan; Docetaxel; Drug Carriers; Drug Delivery Systems; Female; Humans; Hydrogen-Ion Concentration; Hypromellose Derivatives; Intestinal Absorption; Nanoparticles; Particle Size; Vitamin E; X-Ray Diffraction | 2020 |
Preparation and characterization of antioxidant packaging by chitosan, D-α-tocopheryl polyethylene glycol 1000 succinate and baicalein.
Topics: Antioxidants; Chitosan; Flavanones; Food Packaging; Mechanical Phenomena; Solubility; Vitamin E; Water | 2020 |
Hybrid lipid core chitosan-TPGS shell nanocomposites as a promising integrated nanoplatform for enhanced oral delivery of sulpiride in depressive disorder therapy.
Topics: Administration, Oral; Caco-2 Cells; Chitosan; Depressive Disorder; Humans; Lipids; Nanocomposites; Sulpiride; Vitamin E | 2021 |
N-trimethyl chitosan coated nano-complexes enhance the oral bioavailability and chemotherapeutic effects of gemcitabine.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Chitosan; Deoxycytidine; Drug Carriers; Drug Liberation; Gemcitabine; Male; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Neoplasms; Polylactic Acid-Polyglycolic Acid Copolymer; Rats, Sprague-Dawley; Vitamin E | 2021 |
Span 80/TPGS modified lipid-coated chitosan nanocomplexes of acyclovir as a topical delivery system for viral skin infections.
Topics: Acyclovir; Chitosan; Drug Carriers; Drug Delivery Systems; Hexoses; Lipids; Nanoparticles; Particle Size; Vitamin E | 2021 |
Fabrication of D-α-tocopheryl polyethylene glycol 1000 succinates and human serum albumin conjugated chitosan nanoparticles of bosutinib for colon targeting application; in vitro-in vivo investigation.
Topics: Animals; Chitosan; Colorectal Neoplasms; Drug Carriers; Humans; Male; Nanoparticles; Particle Size; Polyethylene Glycols; Rats; Succinates; Vitamin E | 2023 |